North American Consortium for the Study of End-Stage Liver Disease (NACSELD) consists of several tertiary care centers which prospectively studies inpatient and outpatient outcomes in hospitalized patients with cirrhosis. Calculators based on published research predicting 30- day mortality and probability of fungal infection development are included in the App. This is meant for research purposes only.